$0.35
0.87% today
Nasdaq, Apr 01, 06:45 pm CET
ISIN
US00808Y2081
Symbol
AEMD

Aethlon Medical, Inc. Stock price

$0.36
-0.16 30.85% 1M
-0.11 23.24% 6M
-0.50 58.37% YTD
-1.37 79.31% 1Y
-14.24 97.55% 3Y
-14.84 97.64% 5Y
-1,702.14 99.98% 10Y
Nasdaq, Closing price Mon, Mar 31 2025
-0.01 2.37%
ISIN
US00808Y2081
Symbol
AEMD
Sector

Key metrics

Market capitalization $7.40m
Enterprise Value $3.29m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 1.16
Revenue growth (TTM) Revenue growth -100.00%
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-9.82m
Free Cash Flow (TTM) Free Cash Flow $-8.55m
Cash position $4.83m
EPS (TTM) EPS $-1.59
P/E forward negative
Short interest 1.78%
Show more

Is Aethlon Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Aethlon Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Aethlon Medical, Inc. forecast:

1x Buy
50%
1x Hold
50%

Analyst Opinions

2 Analysts have issued a Aethlon Medical, Inc. forecast:

Buy
50%
Hold
50%

Financial data from Aethlon Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
- -
-
100%
- Direct Costs 0.48 0.48
37% 37%
-
-0.48 -0.48
318% 318%
-
- Selling and Administrative Expenses 7.30 7.30
27% 27%
-
- Research and Development Expense 1.56 1.56
38% 38%
-
-9.34 -9.34
24% 24%
-
- Depreciation and Amortization 0.48 0.48
37% 37%
-
EBIT (Operating Income) EBIT -9.82 -9.82
22% 22%
-
Net Profit -9.56 -9.56
22% 22%
-

In millions USD.

Don't miss a Thing! We will send you all news about Aethlon Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Aethlon Medical, Inc. Stock News

Neutral
PRNewsWire
22 days ago
Preclinical Data Suggests Expanded Therapeutic Potential of the Hemopurifier® Beyond Virology and Oncology Results Support Further Evaluation of the Hemopurifier ®  as Part of a Machine Perfusion Circuit to Further Assess its Impact on the Function of Retrieved Kidneys SAN DIEGO , March 10, 2025 /PRNewswire/ -- Aethlon Medical, Inc.  (Nasdaq: AEMD), a medical therapeutic company focused on deve...
Neutral
PRNewsWire
about 2 months ago
Aethlon Medical invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. SAN DIEGO , Feb. 13, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to an...
Neutral
Seeking Alpha
about 2 months ago
Aethlon Medical, Inc. (NASDAQ:AEMD ) Q3 2025 Earnings Conference Call February 12, 2025 4:30 PM ET Company Participants Jim Frakes – Chief Executive Officer Steven LaRosa – Chief Medical Officer Conference Call Participants Marla Marin – Zacks Anthony Vendetti – Maxim Group Operator Good day, and welcome to the Aethlon Medical Third Quarter Fiscal 2025 Earnings and Corporate Update Call. All pa...
More Aethlon Medical, Inc. News

Company Profile

Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.

Head office United States
CEO James Frakes
Employees 14
Founded 1991
Website www.aethlonmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today